In addition, inhibition of FAK increases immune surveillance by overcoming the fibrotic and immunosuppressive tumor microenvironment and makes pancreatic cancer respond to immunotherapy [44,49,60]. This evidence concerns the gene PTK2 and familial pancreatic carcinoma.